Drug · DIN 02362171
PATADAY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 9, 2018; first marketed April 14, 2011.
- Drug Identification Number (DIN)
- 02362171
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Ophthalmic
- Therapeutic class (ATC)
- Olopatadine S01GX09
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OLOPATADINE (OLOPATADINE HYDROCHLORIDE) | 0.2 % | W/V |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 2, 2017: NOC 18933New Drug Submission (NDS) · Transfer of drug identification number
- January 21, 2011: NOC 12018New Drug Submission (NDS)